|
Brandwein, S R; Sipe, J D; Cohen, A S (1994) Combined treatment with terbutaline and aminophylline inhibits experimental amyloidosis in mice. Arthritis Rheum 37:1757-60
|
|
Harding, J; Skare, J; Skinner, M (1991) A second transthyretin mutation at position 33 (Leu/Phe) associated with familial amyloidotic polyneuropathy. Biochim Biophys Acta 1097:183-6
|
|
Jones, L A; Skare, J C; Harding, J A et al. (1991) Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy. Am J Hum Genet 48:979-82
|
|
Skare, J C; Milunsky, J M; Milunsky, A et al. (1991) A new transthyretin variant from a patient with familial amyloidotic polyneuropathy has asparagine substituted for histidine at position 90. Clin Genet 39:6-12
|
|
Shirahama, T; Miura, K; Ju, S T et al. (1990) Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 62:61-8
|
|
Miura, K; Ju, S T; Cohen, A S et al. (1990) Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development. J Immunol 144:610-3
|
|
Skare, J; Yazici, H; Erken, E et al. (1990) Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial amyloidotic polyneuropathy. Hum Genet 86:89-90
|
|
Rokita, H; Shirahama, T; Cohen, A S et al. (1989) Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice. Br J Exp Pathol 70:327-35
|
|
Simms, R W; Goldenberg, D L; Felson, D T et al. (1988) Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum 31:182-7
|
|
Kazis, L E; Anderson, J J; Meenan, R F (1988) Health status information in clinical practice: the development and testing of patient profile reports. J Rheumatol 15:338-44
|
Showing the most recent 10 out of 42 publications
